Dr. Handa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812
Education & Training
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2018 - 2021
- ArMed Forces Medical College PuneClass of 2016
Certifications & Licensure
- OH State Medical License 2024 - 2026
- NY State Medical License 2022 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- HMGA2 overexpression with specific chromosomal abnormalities predominate in CALR and ASXL1 mutated myelofibrosis.Shivani Handa, Christoph Schaniel, Joseph Tripodi, Daiva Ahire, Md Babu Mia
Leukemia. 2024-12-23 - Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy.Shivani Handa, Ganesh Sivakumar, Andrew Srisuwananukorn, Amylou Dueck, Douglas Tremblay
Clinical Lymphoma, Myeloma & Leukemia. 2024-09-01 - The evolving landscape of polycythemia vera therapies.Juana Martinez, Shivani Handa, Alexander Skorodinsky, Marina Kremyanskaya
Expert Opinion on Pharmacotherapy. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: